Recent advances in virtual ligand screening

[11] Consensus scoring for ligand/protein interactions [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2002, 20 (04) : 281 - 295

[12] Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (11) : 2213 - 2221

[13] Pharmacophore-based discovery of 3,4-disubstituted pyrrolidines as a novel glass of monoamine transporter inhibitors [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (09) : 1113 - 1118

[14] Pharmacophore-Based discovery of substituted Pyridines as novel dopamine transporter inhibitors [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 513 - 517

[15] Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1799 - 1805

[16] Successful virtual screening for novel inhibitors of human carbonic anhydrase:: Strategy and experimental confirmation [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) : 3588 - 3602

[17] Guner OsmanF., 2000, PHARMACOPHORE PERCEP

[18] Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) : 1428 - 1440

[19] Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) : 1718 - 1728

[20] A genetic algorithm for flexible molecular overlay and pharmacophore elucidation [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1995, 9 (06) : 532 - 549

[11] Consensus scoring for ligand/protein interactions [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2002, 20 (04) : 281 - 295

[12] Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (11) : 2213 - 2221

[13] Pharmacophore-based discovery of 3,4-disubstituted pyrrolidines as a novel glass of monoamine transporter inhibitors [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (09) : 1113 - 1118

[14] Pharmacophore-Based discovery of substituted Pyridines as novel dopamine transporter inhibitors [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 513 - 517

[15] Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1799 - 1805

[16] Successful virtual screening for novel inhibitors of human carbonic anhydrase:: Strategy and experimental confirmation [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) : 3588 - 3602

[17] Guner OsmanF., 2000, PHARMACOPHORE PERCEP

[18] Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) : 1428 - 1440

[19] Discovery of novel aldose reductase inhibitors using a protein structure-based approach: 3D-database search followed by design and synthesis [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (11) : 1718 - 1728

[20] A genetic algorithm for flexible molecular overlay and pharmacophore elucidation [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1995, 9 (06) : 532 - 549